ABCA6
gene geneOn this page
Also known as EST155051
Summary
ABCA6 (ATP binding cassette subfamily A member 6, HGNC:36) is a protein-coding gene on chromosome 17q24.2-q24.3, encoding ATP-binding cassette sub-family A member 6 (Q8N139). Probable transporter which may play a role in macrophage lipid transport and homeostasis.
The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, and White). This encoded protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This gene is clustered among 4 other ABC1 family members on 17q24 and may play a role in macrophage lipid homeostasis.
Source: NCBI Gene 23460 — RefSeq curated summary.
At a glance
- GWAS associations: 47
- Clinical variants (ClinVar): 256 total — 1 pathogenic
- MANE Select transcript:
NM_080284
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:36 |
| Approved symbol | ABCA6 |
| Name | ATP binding cassette subfamily A member 6 |
| Location | 17q24.2-q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | EST155051 |
| Ensembl gene | ENSG00000154262 |
| Ensembl biotype | protein_coding |
| OMIM | 612504 |
| Entrez | 23460 |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 13 protein_coding, 3 retained_intron, 2 protein_coding_CDS_not_defined
ENST00000284425, ENST00000446604, ENST00000589482, ENST00000589803, ENST00000590311, ENST00000590645, ENST00000592493, ENST00000886834, ENST00000886835, ENST00000886836, ENST00000886837, ENST00000886838, ENST00000886839, ENST00000886840, ENST00000886841, ENST00000886842, ENST00000886843, ENST00000886844
RefSeq mRNA: 1 — MANE Select: NM_080284
NM_080284
CCDS: CCDS11683
Canonical transcript exons
ENST00000284425 — 39 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001104933 | 69136092 | 69136250 |
| ENSE00001104948 | 69137296 | 69137500 |
| ENSE00001104975 | 69123239 | 69123407 |
| ENSE00001104999 | 69128619 | 69128804 |
| ENSE00001105004 | 69124888 | 69125035 |
| ENSE00001105007 | 69133641 | 69133867 |
| ENSE00001105009 | 69134639 | 69134742 |
| ENSE00001148863 | 69140608 | 69140748 |
| ENSE00001187403 | 69141745 | 69141895 |
| ENSE00002209282 | 69078702 | 69079074 |
| ENSE00002267967 | 69100797 | 69100934 |
| ENSE00002270224 | 69102835 | 69102968 |
| ENSE00002321969 | 69105462 | 69105628 |
| ENSE00002444236 | 69117898 | 69117956 |
| ENSE00002503998 | 69129610 | 69129751 |
| ENSE00003460624 | 69114762 | 69114937 |
| ENSE00003461731 | 69107696 | 69107812 |
| ENSE00003461881 | 69084432 | 69084507 |
| ENSE00003468597 | 69091143 | 69091262 |
| ENSE00003491191 | 69083212 | 69083331 |
| ENSE00003511911 | 69086618 | 69086735 |
| ENSE00003537371 | 69112183 | 69112273 |
| ENSE00003545539 | 69088167 | 69088258 |
| ENSE00003555465 | 69085625 | 69085716 |
| ENSE00003592732 | 69115376 | 69115486 |
| ENSE00003595372 | 69097920 | 69098027 |
| ENSE00003621292 | 69113618 | 69113737 |
| ENSE00003622654 | 69113222 | 69113360 |
| ENSE00003628884 | 69085028 | 69085182 |
| ENSE00003652298 | 69079210 | 69079265 |
| ENSE00003653379 | 69081066 | 69081145 |
| ENSE00003656256 | 69106028 | 69106211 |
| ENSE00003662870 | 69089465 | 69089542 |
| ENSE00003670969 | 69082873 | 69083013 |
| ENSE00003675600 | 69096628 | 69096801 |
| ENSE00003677830 | 69096240 | 69096353 |
| ENSE00003682478 | 69087353 | 69087473 |
| ENSE00003687889 | 69084261 | 69084355 |
| ENSE00003692778 | 69110801 | 69110940 |
Expression profiles
Bgee: expression breadth ubiquitous, 206 present calls, max score 96.94.
FANTOM5 (CAGE): breadth broad, TPM avg 3.6611 / max 325.6449, expressed in 558 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 167781 | 2.7177 | 500 |
| 167782 | 0.3782 | 184 |
| 167780 | 0.2374 | 106 |
| 167774 | 0.1388 | 26 |
| 167775 | 0.0665 | 21 |
| 167779 | 0.0568 | 26 |
| 167773 | 0.0360 | 6 |
| 167783 | 0.0297 | 11 |
Top tissues by expression
270 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 96.94 | gold quality |
| tibial nerve | UBERON:0001323 | 96.13 | gold quality |
| mucosa of stomach | UBERON:0001199 | 96.10 | gold quality |
| sural nerve | UBERON:0015488 | 95.20 | gold quality |
| right lung | UBERON:0002167 | 95.17 | gold quality |
| left ovary | UBERON:0002119 | 94.88 | gold quality |
| right lobe of liver | UBERON:0001114 | 94.78 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 94.06 | gold quality |
| right ovary | UBERON:0002118 | 93.23 | gold quality |
| omental fat pad | UBERON:0010414 | 92.95 | gold quality |
| peritoneum | UBERON:0002358 | 92.81 | gold quality |
| apex of heart | UBERON:0002098 | 92.77 | gold quality |
| right atrium auricular region | UBERON:0006631 | 92.77 | gold quality |
| liver | UBERON:0002107 | 92.48 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 92.28 | gold quality |
| cardiac atrium | UBERON:0002081 | 91.52 | gold quality |
| adipose tissue | UBERON:0001013 | 90.37 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 90.27 | gold quality |
| right coronary artery | UBERON:0001625 | 89.75 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 89.63 | gold quality |
| lower esophagus | UBERON:0013473 | 89.59 | gold quality |
| left coronary artery | UBERON:0001626 | 89.35 | gold quality |
| connective tissue | UBERON:0002384 | 89.30 | gold quality |
| tendon | UBERON:0000043 | 88.68 | gold quality |
| minor salivary gland | UBERON:0001830 | 88.56 | gold quality |
| coronary artery | UBERON:0001621 | 88.17 | gold quality |
| endocervix | UBERON:0000458 | 88.12 | gold quality |
| colonic epithelium | UBERON:0000397 | 87.98 | gold quality |
| heart | UBERON:0000948 | 87.68 | gold quality |
| heart left ventricle | UBERON:0002084 | 87.60 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-2 | yes | 3292.26 |
| E-MTAB-11268 | yes | 1444.49 |
| E-GEOD-180759 | yes | 982.61 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting ABCA6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-7159-5P | 99.53 | 72.12 | 2472 |
| HSA-MIR-6507-5P | 99.36 | 70.46 | 2524 |
| HSA-MIR-10522-5P | 99.26 | 68.50 | 2087 |
| HSA-MIR-1262 | 98.17 | 66.52 | 757 |
| HSA-MIR-4701-3P | 98.17 | 66.25 | 788 |
| HSA-MIR-6736-5P | 98.17 | 66.43 | 760 |
| HSA-MIR-3144-3P | 98.15 | 67.34 | 677 |
| HSA-MIR-6802-3P | 97.29 | 65.42 | 613 |
| HSA-MIR-6888-5P | 95.89 | 63.78 | 831 |
| HSA-MIR-4683 | 95.29 | 65.98 | 631 |
Literature-anchored findings (GeneRIF, showing 6)
- These data provide evidence for an essential role of FoxO proteins in the transcription of ABCA6 in human vascular endothelial cells. (PMID:24028821)
- Results suggest a possible role for multidrug resistance genes ABCA10 and ABCA6 in follicular lymphoma survival and add to the evidence that genetic variation in CD46 and IL8 may have prognostic implications follicular lymphoma. (PMID:25294155)
- A rare missense variant in ABCA6 (rs77542162, p.Cys1359Arg, frequency 0.034), found in a Dutch population, is predicted to be deleterious with respect to blood cholesterol levels. (PMID:25751400)
- The Evolution of the Mammalian ABCA6-like Genes: Analysis of Phylogenetic, Expression, and Population Genetic Data Reveals Complex Evolutionary Histories. (PMID:32877505)
- Hypercholesterolemia risk associated Abca6 does not regulate lipoprotein metabolism in mice or hamster. (PMID:34274505)
- ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis. (PMID:36149602)
Cross-species orthologs
16 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | abca5 | ENSDARG00000074041 |
| mus_musculus | Abca6 | ENSMUSG00000044749 |
| rattus_norvegicus | Abca6 | ENSRNOG00000046890 |
| drosophila_melanogaster | Eato | FBGN0028539 |
| drosophila_melanogaster | CG1494 | FBGN0031169 |
| drosophila_melanogaster | Abca3 | FBGN0031170 |
| drosophila_melanogaster | CG1801 | FBGN0031171 |
| drosophila_melanogaster | CG8908 | FBGN0034493 |
| drosophila_melanogaster | CG6052 | FBGN0036747 |
| drosophila_melanogaster | CG31213 | FBGN0051213 |
| drosophila_melanogaster | ldd | FBGN0083956 |
| drosophila_melanogaster | CG43672 | FBGN0263747 |
| caenorhabditis_elegans | WBGENE00000019 | |
| caenorhabditis_elegans | abt-2 | WBGENE00000020 |
| caenorhabditis_elegans | WBGENE00000022 | |
| caenorhabditis_elegans | abt-5 | WBGENE00000023 |
Paralogs (11): ABCA7 (ENSG00000064687), ABCA2 (ENSG00000107331), ABCA8 (ENSG00000141338), ABCA12 (ENSG00000144452), ABCA9 (ENSG00000154258), ABCA10 (ENSG00000154263), ABCA5 (ENSG00000154265), ABCA1 (ENSG00000165029), ABCA3 (ENSG00000167972), ABCA13 (ENSG00000179869), ABCA4 (ENSG00000198691)
Protein
Protein identifiers
ATP-binding cassette sub-family A member 6 — Q8N139 (reviewed: Q8N139)
All UniProt accessions (1): Q8N139
UniProt curated annotations — full annotation on UniProt →
Function. Probable transporter which may play a role in macrophage lipid transport and homeostasis.
Subcellular location. Golgi apparatus membrane.
Tissue specificity. Widely expressed with higher expression in liver.
Induction. Up-regulated during monocyte differentiation into macrophages. Down-regulated by cholesterol loading of macrophages.
Similarity. Belongs to the ABC transporter superfamily. ABCA family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N139-1 | 1 | yes |
| Q8N139-2 | 2, ABCA6delta-139 | |
| Q8N139-3 | 3 |
RefSeq proteins (1): NP_525023* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003439 | ABC_transporter-like_ATP-bd | Domain |
| IPR003593 | AAA+_ATPase | Domain |
| IPR013525 | ABC2_TM | Domain |
| IPR026082 | ABCA | Family |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR056264 | R2_ABCA1-4-like | Domain |
Pfam: PF00005, PF12698, PF23321
UniProt features (35 total): transmembrane region 14, sequence variant 5, splice variant 4, sequence conflict 4, glycosylation site 3, domain 2, binding site 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N139-F1 | 77.38 | 0.13 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (2): 514–521; 1320–1327
Glycosylation sites (3): 84, 109, 940
Function
Pathways and Gene Ontology
Reactome pathways
8 pathways
| ID | Pathway |
|---|---|
| R-HSA-1369062 | ABC transporters in lipid homeostasis |
| R-HSA-9615017 | FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes |
| R-HSA-212436 | Generic Transcription Pathway |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-382556 | ABC-family protein mediated transport |
| R-HSA-73857 | RNA Polymerase II Transcription |
| R-HSA-74160 | Gene expression (Transcription) |
| R-HSA-9614085 | FOXO-mediated transcription |
MSigDB gene sets: 111 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_UP, BROWNE_HCMV_INFECTION_8HR_UP, CEBPB_01, KEGG_ABC_TRANSPORTERS, BROWNE_HCMV_INFECTION_48HR_DN, CAIRO_HEPATOBLASTOMA_CLASSES_DN, HFH4_01, CORRE_MULTIPLE_MYELOMA_UP, BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN, GOBP_LIPID_LOCALIZATION, NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON, GOBP_TRANSMEMBRANE_TRANSPORT, CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN, PAX2_02, GOMF_LIPID_TRANSPORTER_ACTIVITY
GO Biological Process (2): lipid transport (GO:0006869), transmembrane transport (GO:0055085)
GO Molecular Function (6): lipid carrier activity (GO:0005319), ATP binding (GO:0005524), ATP hydrolysis activity (GO:0016887), ATPase-coupled transmembrane transporter activity (GO:0042626), ABC-type transporter activity (GO:0140359), nucleotide binding (GO:0000166)
GO Cellular Component (5): Golgi membrane (GO:0000139), nucleoplasm (GO:0005654), plasma membrane (GO:0005886), Golgi apparatus (GO:0005794), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-6 pathways:
| Category | Pathways |
|---|---|
| ABC-family protein mediated transport | 1 |
| FOXO-mediated transcription | 1 |
| RNA Polymerase II Transcription | 1 |
| Transport of small molecules | 1 |
| Gene expression (Transcription) | 1 |
| Generic Transcription Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 2 |
| ATP-dependent activity | 2 |
| cellular anatomical structure | 2 |
| lipid localization | 1 |
| cellular process | 1 |
| molecular carrier activity | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| primary active transmembrane transporter activity | 1 |
| ATP hydrolysis activity | 1 |
| ATPase-coupled transmembrane transporter activity | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| Golgi apparatus | 1 |
| bounding membrane of organelle | 1 |
| nuclear lumen | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1004 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ABCA6 | MAP2K6 | P52564 | 594 |
| ABCA6 | SLC22A8 | Q8TCC7 | 511 |
| ABCA6 | ABCF3 | Q9NUQ8 | 462 |
| ABCA6 | ABCC3 | O15438 | 444 |
| ABCA6 | APOD | P05090 | 416 |
| ABCA6 | ABCD4 | O14678 | 407 |
| ABCA6 | ABCA12 | Q86UK0 | 395 |
| ABCA6 | SLC27A6 | Q9Y2P4 | 394 |
| ABCA6 | ABCA8 | O94911 | 389 |
| ABCA6 | MSLNL | Q96KJ4 | 387 |
| ABCA6 | SLCO1B1 | Q9Y6L6 | 376 |
| ABCA6 | MRAS | O14807 | 362 |
| ABCA6 | SARM1 | Q6SZW1 | 353 |
| ABCA6 | ABCF1 | Q8NE71 | 346 |
| ABCA6 | ABCB1 | P08183 | 343 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| APOA1 | CNMD | psi-mi:“MI:0914”(association) | 0.350 |
| ABCA6 | STX6 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (16): ABCA10 (Affinity Capture-MS), DNAJC30 (Affinity Capture-MS), ABCA8 (Affinity Capture-MS), STX6 (Affinity Capture-MS), FADS1 (Affinity Capture-MS), ANKLE2 (Affinity Capture-MS), CISD3 (Affinity Capture-MS), ABCA2 (Affinity Capture-MS), ABCA6 (Affinity Capture-MS), ABCA6 (Proximity Label-MS), ABCA6 (Proximity Label-MS), ABCA6 (Proximity Label-MS), ABCA6 (Proximity Label-MS), ABCA6 (Proximity Label-MS), ABCA6 (Proximity Label-MS)
ESM2 similar proteins: A0A0G2K1Q8, B2RX12, E9PU17, E9PX95, F1MWM0, O00329, O15438, O35600, O75899, O88563, O88871, O94911, O95477, P41233, P55205, P58428, P78363, Q09427, Q09428, Q09429, Q2NKY8, Q5BJS0, Q5R607, Q5ZI74, Q6TL19, Q7L2E3, Q7TNJ2, Q80T41, Q84M24, Q8CF82, Q8IUA7, Q8K440, Q8K441, Q8K442, Q8K448, Q8K449, Q8LPK0, Q8N139, Q8NCL4, Q8R420
Diamond homologs: A0A059J0G5, A0A0M3R8G1, A0A1L9WQK0, A0A1U8QKX8, A0A1U8QT10, A0A1V0QSE4, A0A1V1GB10, A0A1Y0BRF0, A0A2H1A768, A0A2U8U2K9, A0A481WQK1, A0A4P8GG95, A0A8K1AW53, A1C8C8, A1CFM0, A9YWR6, B6HV31, B6RAL1, B8NDS8, B9G5Y5, D3GE74, D4AYW0, E9RBG1, F2PLH2, F2RSQ6, F2SG60, F2SHL1, G3JF11, I1RL06, J9VME1, J9VPA2, M2UCE5, O42690, O65934, O74208, O74676, P32568, P33302, P40550, P41820
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
256 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 207 |
| Likely benign | 25 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 685257 | GRCh37/hg19 17q23.1-24.2(chr17:57869604-67078443)x3 | Pathogenic |
SpliceAI
5892 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:69079208:A:AC | donor_gain | 1.0000 |
| 17:69079209:C:CA | donor_loss | 1.0000 |
| 17:69079209:C:CC | donor_gain | 1.0000 |
| 17:69079209:CCTT:C | donor_gain | 1.0000 |
| 17:69079261:CTTCA:C | acceptor_gain | 1.0000 |
| 17:69079262:TTCA:T | acceptor_gain | 1.0000 |
| 17:69079263:TCA:T | acceptor_gain | 1.0000 |
| 17:69079264:CA:C | acceptor_gain | 1.0000 |
| 17:69079264:CAC:C | acceptor_gain | 1.0000 |
| 17:69079265:AC:A | acceptor_loss | 1.0000 |
| 17:69079266:C:CC | acceptor_gain | 1.0000 |
| 17:69082867:TCTCA:T | donor_loss | 1.0000 |
| 17:69082868:CTCA:C | donor_loss | 1.0000 |
| 17:69082869:TCAC:T | donor_loss | 1.0000 |
| 17:69082870:CAC:C | donor_loss | 1.0000 |
| 17:69082871:A:T | donor_loss | 1.0000 |
| 17:69082872:CCTT:C | donor_loss | 1.0000 |
| 17:69082876:T:A | donor_gain | 1.0000 |
| 17:69083011:CAT:C | acceptor_gain | 1.0000 |
| 17:69083012:ATC:A | acceptor_loss | 1.0000 |
| 17:69083013:TCTAT:T | acceptor_loss | 1.0000 |
| 17:69083014:C:CC | acceptor_gain | 1.0000 |
| 17:69083014:CT:C | acceptor_loss | 1.0000 |
| 17:69083015:T:C | acceptor_loss | 1.0000 |
| 17:69083214:AAG:A | donor_gain | 1.0000 |
| 17:69084353:CAA:C | acceptor_gain | 1.0000 |
| 17:69084356:C:CC | acceptor_gain | 1.0000 |
| 17:69084427:CGTA:C | donor_loss | 1.0000 |
| 17:69084428:GTAC:G | donor_loss | 1.0000 |
| 17:69084429:TACC:T | donor_loss | 1.0000 |
AlphaMissense
10715 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:69128649:G:C | S363R | 0.986 |
| 17:69128649:G:T | S363R | 0.986 |
| 17:69128651:T:G | S363R | 0.986 |
| 17:69102861:C:G | A950P | 0.981 |
| 17:69100863:G:C | S982R | 0.977 |
| 17:69100863:G:T | S982R | 0.977 |
| 17:69100865:T:G | S982R | 0.977 |
| 17:69100890:A:C | C973W | 0.976 |
| 17:69100911:A:C | C966W | 0.966 |
| 17:69100913:A:G | C966R | 0.964 |
| 17:69113652:A:G | L623P | 0.963 |
| 17:69112186:A:G | L710P | 0.961 |
| 17:69113256:A:C | S669R | 0.959 |
| 17:69113256:A:T | S669R | 0.959 |
| 17:69113258:T:G | S669R | 0.959 |
| 17:69084338:G:C | S1426R | 0.958 |
| 17:69084338:G:T | S1426R | 0.958 |
| 17:69084340:T:G | S1426R | 0.958 |
| 17:69100892:A:G | C973R | 0.958 |
| 17:69086626:A:T | V1310D | 0.957 |
| 17:69083242:C:G | R1482P | 0.956 |
| 17:69114814:A:G | L577P | 0.956 |
| 17:69137362:A:C | Y79D | 0.955 |
| 17:69134650:C:G | A185P | 0.954 |
| 17:69102851:A:T | V953D | 0.953 |
| 17:69100923:A:C | F962L | 0.952 |
| 17:69100923:A:T | F962L | 0.952 |
| 17:69100925:A:G | F962L | 0.952 |
| 17:69136165:A:C | F129L | 0.952 |
| 17:69136165:A:T | F129L | 0.952 |
dbSNP variants (sampled 300 via entrez): RS1000121805 (17:69062869 T>C), RS1000199865 (17:69140844 T>A), RS1000283661 (17:69101723 A>C), RS1000311054 (17:69074356 C>T), RS1000312824 (17:69087779 T>C), RS1000344004 (17:69073969 T>A), RS1000377231 (17:69081910 G>GT), RS1000382172 (17:69119956 T>C), RS1000387041 (17:69133320 A>G), RS1000406988 (17:69094924 C>G), RS1000437807 (17:69094752 G>C), RS1000494072 (17:69109131 T>C), RS1000494590 (17:69100273 C>T), RS1000534062 (17:69142563 A>C), RS1000570636 (17:69067660 AGAAAGAAG>A)
Disease associations
OMIM: gene MIM:612504 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
47 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002896_42 | Cholesterol, total | 2.000000e-13 |
| GCST002898_37 | LDL cholesterol | 2.000000e-18 |
| GCST003031_2 | MGMT methylation in smokers | 2.000000e-07 |
| GCST004602_298 | Mean corpuscular volume | 3.000000e-12 |
| GCST004604_34 | Hematocrit | 2.000000e-13 |
| GCST004615_116 | Hemoglobin concentration | 2.000000e-16 |
| GCST004630_220 | Mean corpuscular hemoglobin | 2.000000e-13 |
| GCST005580_121 | Intraocular pressure | 8.000000e-21 |
| GCST006612_74 | LDL cholesterol | 4.000000e-52 |
| GCST006614_59 | Total cholesterol levels | 2.000000e-33 |
| GCST007931_27 | Medication use (HMG CoA reductase inhibitors) | 6.000000e-16 |
| GCST007931_54 | Medication use (HMG CoA reductase inhibitors) | 2.000000e-09 |
| GCST008077_21 | LDL cholesterol levels | 2.000000e-07 |
| GCST008077_85 | LDL cholesterol levels | 2.000000e-06 |
| GCST008078_149 | LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 9.000000e-33 |
| GCST008078_58 | LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 6.000000e-32 |
| GCST008079_4 | LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 3.000000e-33 |
| GCST008079_46 | LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 5.000000e-32 |
| GCST008086_24 | LDL cholesterol levels in current drinkers | 6.000000e-14 |
| GCST008086_36 | LDL cholesterol levels in current drinkers | 1.000000e-15 |
| GCST008277_5 | Corneal hysteresis | 7.000000e-11 |
| GCST010083_148 | Hemoglobin levels | 6.000000e-36 |
| GCST010204_7 | Low density lipoprotein cholesterol levels | 2.000000e-98 |
| GCST010241_41 | Apolipoprotein A1 levels | 2.000000e-15 |
| GCST010243_170 | Apolipoprotein B levels | 1.000000e-60 |
| GCST010245_222 | LDL cholesterol levels | 6.000000e-74 |
| GCST011346_34 | Total cholesterol levels | 1.000000e-12 |
| GCST011347_55 | Low density lipoprotein cholesterol levels | 1.000000e-13 |
| GCST011390_10 | Corneal resistance factor | 2.000000e-78 |
| GCST011391_8 | Corneal hysteresis | 7.000000e-66 |
EFO canonical traits (19, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004574 | total cholesterol measurement |
| EFO:0004611 | low density lipoprotein cholesterol measurement |
| EFO:0006959 | gene methylation measurement |
| EFO:0004348 | hematocrit |
| EFO:0004509 | hemoglobin measurement |
| EFO:0004527 | mean corpuscular hemoglobin |
| EFO:0004695 | intraocular pressure measurement |
| EFO:0009932 | HMG CoA reductase inhibitor use measurement |
| EFO:0004329 | alcohol drinking |
| EFO:0010066 | corneal hysteresis |
| EFO:0004614 | apolipoprotein A 1 measurement |
| EFO:0004615 | apolipoprotein B measurement |
| EFO:0010067 | corneal resistance factor |
| EFO:0600007 | fish oil supplement exposure measurement |
| EFO:0006925 | lipoprotein A measurement |
| EFO:0008343 | sex interaction measurement |
| EFO:0004980 | appendicular lean mass |
| EFO:0009188 | Red cell distribution width |
| EFO:0004533 | alkaline phosphatase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — ABCA subfamily
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 2 |
| nickel sulfate | decreases expression | 2 |
| Acetaminophen | decreases expression | 2 |
| Benzo(a)pyrene | decreases expression, increases methylation, affects methylation | 2 |
| Carbamazepine | affects expression, increases expression | 2 |
| Valproic Acid | decreases expression, decreases methylation | 2 |
| Aflatoxin B1 | decreases expression, decreases methylation | 2 |
| bisphenol F | increases expression | 1 |
| methyleugenol | decreases expression | 1 |
| propylparaben | decreases expression | 1 |
| lead acetate | decreases expression | 1 |
| cupric chloride | decreases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| 2,2’,4,4’,5-brominated diphenyl ether | decreases expression | 1 |
| bisphenol S | decreases expression | 1 |
| incobotulinumtoxinA | increases expression | 1 |
| Docetaxel | increases expression, decreases response to substance | 1 |
| Benzalkonium Compounds | decreases expression | 1 |
| Cadmium | decreases expression | 1 |
| Cisplatin | affects response to substance | 1 |
| Dexamethasone | increases expression | 1 |
| Dinitrochlorobenzene | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Eugenol | decreases expression | 1 |
| Nickel | decreases expression | 1 |
| Oxazolone | decreases expression | 1 |
| Phenobarbital | affects expression | 1 |
| Progesterone | increases expression | 1 |
| Sodium Dodecyl Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.